CBAK Energy Technology (BD5) Q4 2025 Earnings Report

The call conveyed strong top-line momentum, a robust turnaround in the raw materials segment (Hitrans), meaningful cash generation, major capacity additions and expanding global commercial partnerships — all signaling growth potential. Offsetting these positives were substantial margin compression, reported operating and net losses for both the quarter and full year, and timing risks as new production lines ramp. Management frames the losses as temporary, driven by strategic investments and capacity transitions that should unlock larger scale and improved margins in 2026–2027.

Management guided that consolidated sales should hit a record high in 2026 as new capacity ramps complete — the Dalian 40135 line (2.3 GWh commissioned end‑2025) is in intensive ramp with demand > supply and is expected to finish ramping in H1 2026, while Nanjing added two Phase II lines (+3.0 GWh to complement 1.5 GWh Phase I) targeted to reach full capacity in early 2027 (management hopes H2 2026 if possible). They expect gross margins, which compressed to 7.3% in Q4 and 9.4% for FY2025 (vs. 13.1% and 23.7% prior year), to gradually recover in 2H 2026 and improve for full‑year 2026 as yields and fixed‑cost absorption normalize. Management pointed to Hitrans’ momentum (FY revenue $89.21M, +123% YoY) and planned capacity additions — a 10,000 MT cathode plant and 37,000 MT precursor facility with the cathode plant slated for full operation in H1 2027 — as additional upside, reiterated balance sheet strength ($75.68M cash, $48.55M net cash from operations, $44.65M capex spent in 2025), noted R&D of $15.8M (up 21%) to accelerate large‑format and sodium‑ion programs, and flagged export tax rebate cuts (13%→9%→6%→0% by Jan 2027) as a driver of their Malaysia localization plan (subsidiary incorporated Apr 30, 2025).